2-(2-(trifluoromethyl)phenyl)benzo[d]oxazole-7-carboxylic acid | 594839-81-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-(2-(trifluoromethyl)phenyl)benzo[d]oxazole-7-carboxylic acid
• 英文别名: 2-[2-(Trifluoromethyl)phenyl]benzoxazole-7-carboxylic acid；2-[2-(trifluoromethyl)phenyl]-1,3-benzoxazole-7-carboxylic acid
• CAS: 594839-81-3
• 化学式: C₁₅H₈F₃NO₃
• 分子量: 307.229
• InChiKey: PVKMOKYTTVUKLT-UHFFFAOYSA-N

物化性质

• 沸点：
  426.5±45.0 °C(Predicted)
• 密度：
  1.456±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  63.3
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  2-(2-(trifluoromethyl)phenyl)benzo[d]oxazole-7-carboxylic acid 、 三甲基硅烷化重氮甲烷 以 甲醇 、 苯 为溶剂， 生成 2-(2-Trifluoromethyl-phenyl)-benzooxazole-7-carboxylic acid methyl ester
  参考文献：
  名称：

  苯并恶唑作为运甲状腺素蛋白淀粉样蛋白原纤维抑制剂：合成，评估和作用机理。

  摘要：

  DOI：

  10.1002/anie.200351179
• 作为产物：
  描述：

  在 对甲苯磺酸 作用下， 以 xylene 为溶剂， 生成 2-(2-(trifluoromethyl)phenyl)benzo[d]oxazole-7-carboxylic acid
  参考文献：
  名称：

  苯并恶唑作为运甲状腺素蛋白淀粉样蛋白原纤维抑制剂：合成，评估和作用机理。

  摘要：

  DOI：

  10.1002/anie.200351179

文献信息

• [EN] BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS<br/>[FR] BENZOXAZOLES, BENZTHIAZOLES ET ANALOGUES APPARENTÉS EN TANT QUE MODULATEURS DE LA SIRTUINE
  申请人：SIRTRIS PHARMACEUTICALS INC

  公开号：WO2010019606A1

  公开（公告）日：2010-02-18

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin- modulating compound in combination with another therapeutic agent.

  本文提供了新颖的调节sirtuin的化合物及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并治疗和/或预防包括与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块性疾病、炎症、癌症和/或潮红等相关的各种疾病和紊乱。还提供了含有sirtuin调节化合物与另一治疗剂结合的组合物。
• METHODS FOR TREATING TRANSTHYRETIN AMYLOID DISEASES
  申请人：KELLY Jeffery W.

  公开号：US20120065237A1

  公开（公告）日：2012-03-15

  Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods are disclosed.

  动力学稳定化甲状腺素转运蛋白的天然状态是防止蛋白质错误折叠的有效机制。因为甲状腺素转运蛋白的错误折叠在甲状腺素转运蛋白淀粉样疾病中扮演重要角色，抑制这种错误折叠可以用作有效的治疗或预防这种疾病的方法。本文公开了治疗方法。
• Methods for treating transthyretin amyloid diseases
  申请人：Kelly W. Jeffery

  公开号：US20070078186A1

  公开（公告）日：2007-04-05

  Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods are disclosed.

  转甲状腺素原生态稳定化是预防蛋白质错构的有效机制，因为转甲状腺素的错构在转甲状腺素淀粉样病中扮演着重要角色，抑制此类错构可用作该类疾病的有效治疗或预防。披露了治疗方法。
• BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS
  申请人：Vu Chi B.

  公开号：US20120108585A1

  公开（公告）日：2012-05-03

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新颖的调节sirtuin的化合物及其使用方法。这些sirtuin调节化合物可用于增加细胞寿命，并治疗和/或预防各种疾病和疾病，包括与衰老或应激相关的疾病或疾病，糖尿病，肥胖症，神经退行性疾病，心血管疾病，血液凝结障碍，炎症，癌症和/或红斑病，以及需要增加线粒体活性的疾病或疾病。还提供了包含sirtuin调节化合物与另一种治疗剂组合的组合物。
• Compositions and method for stabilizing transthyretin and inhibiting transthyretin misfolding
  申请人：The Scripps Research Institute

  公开号：EP1988397A1

  公开（公告）日：2008-11-05

  Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods, screening methods, as well as specific transthyretin stabilizing compounds are disclosed.

  转甲状腺素原生态的动力学稳定是防止蛋白质错误折叠的有效机制。由于转甲状腺素错误折叠在转甲状腺素淀粉样变性疾病中起着重要作用，因此抑制这种错误折叠可作为治疗或预防此类疾病的有效方法。本文公开了治疗方法、筛选方法以及特异性转甲状腺素稳定化合物。